Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Convalescent plasma Emergency use authorization Experimental Antiviral Apr/10/2021 37 6
ACE2‐Fc Potential treatment - pre-clinical evidence Experimental Antiviral Mar/20/2021 4 0
Lopinavir Recommended by China's NHC Guidelines Used to treat other disease Antiviral Mar/01/2021 26 14
Ritonavir Recommended by China's NHC Guidelines Used to treat other disease Antiviral Feb/12/2021 26 13
12f Potential treatment - pre-clinical evidence Experimental Antiviral Feb/08/2021 1 0
Salvianolic acid C Potential treatment - pre-clinical evidence Natural product Antiviral Feb/08/2021 2 0
ZINC104875569 Potential treatment - theoretical effect Experimental Antiviral Feb/08/2021 1 0
(2s,3r)-2-(3,4-Dihydroxyphenyl)-3,7-dihydroxy-2,3-dihydro-4h-chromen-4-one Potential treatment - theoretical effect Experimental Antiviral Feb/08/2021 1 0
S-8510 Potential treatment - theoretical effect Experimental Antiviral Feb/08/2021 1 0
gp96-Ig-S Potential treatment - pre-clinical evidence Experimental Vaccine Jan/26/2021 1 0